Berkeley Lights, Inc. Rings the Opening Bell in Celebration of its IPO

As We Wait for a Vaccine, Scientists Work to Scale Up the Best COVID-19 Antibodies to Give New Patients

Get to IND Faster: Accelerated and High-Performance Cell-Line Development

Optofluidics Aids Cell Line Development for Antibody-Based Therapies

Antibody Therapies to Cure Coronavirus Now Under Human Trial Phase

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

The Race Is On to Find the Holy Grail of Covid-19 Antibodies

Antibody Shots Could Give Short-Term Doses of COVID-19 Protection. Will They Arrive before a Vaccine?

The Hope behind Antibody Treatments as a Quick Coronavirus Fix

How to Prevent Another COVID-19? ‘Invest in Infrastructure’

Finding the Best Cells for Faster Drug Discovery

Apple Founder Zoom-Bombs Meeting To Thank COVID-19 Scientists

Company Focuses on Finding Coronavirus Antibodies in Push for New Therapeutics

Beyond Testing: The Importance of Antibodies in Tackling Covid-19

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Engineering During a Pandemic

The Race to Find a Covid-19 Drug in the Blood of Survivors

Timeline Shows 3 Paths to COVID-19 Treatment and Prevention

1
2
3